Sanofi Pasteur

From Infogalactic: the planetary knowledge core
Jump to: navigation, search
sanofi pasteur
Public
Founded August 2004 by merger
Headquarters Lyon, France
Key people
Olivier Charmeil Executive Vice President, Vaccines
Parent Sanofi
Slogan Because health matters. (French: L'essentiel c'est la santé.)
Website sanofipasteur.com

Sanofi Pasteur is the vaccines division of the multinational pharmaceutical company Sanofi. Sanofi Pasteur is the largest company in the world devoted entirely to vaccines.

History

In 1994, Aventis merged with and into Sanofi. The new Sanofi-Aventis Group became the world's 3rd largest pharmaceutical company. Aventis Pasteur, the vaccine division[1] of Sanofi-Aventis Group, changed its name to Sanofi Pasteur.[2] In 2014, Sanofi Pasteur stopped producing its effective Fav-Afrique antivenom because competition from cheaper though less powerful competitors made it unprofitable.[3] Doctors Without Borders said that it would take two years to develop a similar antivenom, and that existing stocks will run out in June 2016.[3]

Key dates

  • 1897: Marcel Mérieux creates the Mérieux Biological Institute in Lyon. Richard Slee creates the Pocono Biological Laboratories, in Swiftwater, Pennsylvania in the U.S.[4]
  • 1914: John FitzGerald creates Connaught Laboratories,[5] part of the University of Toronto.
  • 1968: Rhône-Poulenc acquires 51% of the capital of the Institut Mérieux.
  • 1974: Pasteur Institute creates Pasteur Production, a subsidiary specializing in manufacturing vaccines.
  • 1978: Connaught Laboratories in Canada acquires the vaccine manufacturing facility (Merrell-National Laboratories) at Swiftwater, Pennsylvania, U.S.
  • 1985: Pasteur Production is acquired by the Mérieux Institute, and Pasteur Vaccins is created.
  • 1989: The Mérieux Institute acquires the Connaught Laboratories in Canada and its subsidiaries and becomes a world leader in human biology.
  • 1990: Creation of Pasteur Mérieux Serums & Vaccins.
  • 1994: Pasteur Mérieux Sérums & Vaccins becomes a wholly owned subsidiary of Rhône-Poulenc.
  • 1996: Pasteur Mérieux Connaught is the new name of Pasteur Mérieux Serums et Vaccins.
  • 1999: Rhône-Poulenc and Hoechst unite their Life Sciences activities in a single company, which takes on the name Aventis. Within this group, Pasteur Mérieux Connaught changes its name to Aventis Pasteur.
  • 2004: merger of Aventis with and into Sanofi. The new Sanofi-Aventis Group becomes the world's 3rd largest pharmaceutical company, behind Pfizer and GlaxoSmithKline. Aventis Pasteur, the vaccine division of the Sanofi-Aventis Group, changes its name to Sanofi Pasteur.
  • 2008: Sanofi Pasteur acquires Acambis plc, a biotech company.
  • 2009: Sanofi Pasteur acquires major stake in Hyderabad-based Shantha Biotechnics.[6]

Key facts & figures in 2012

Sanofi Pasteur

Vaccines

External links

References

  1. "Sanofi Pasteur Vaccine Hub". www.vaccinehub.com.au. Retrieved 1 March 2014.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  2. "sanofi-aventis : Sanofi Pasteur, the vaccine division of the Sanofi-aventis Group, changes its name to sanofi pasteur". Retrieved 2007-11-04.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  3. 3.0 3.1 Associated Press (7 September 2015). "Snakebite anti-venom running out worldwide, MSF". CBC News. Retrieved 8 September 2015.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  4. "Why vaccinate?". www.vaccinehub.com.au. Retrieved 1 March 2014.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  5. "Connaught and the Canadian Polio Vaccine Story +". CONNTACT, June 1996 (Vol. 9 No. 3) (Employee News of Connaught Laboratories Limited). Retrieved 11 December 2012.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  6. http://www.thehindubusinessline.com/companies/article2101029.ece
  7. http://en.sanofi.com/our_company/news/2012-01-24_headquarter.aspx
  8. http://www.sanofipasteur.us/
  9. http://www.sanofi.fr/l/fr/fr/layout.jsp?cnt=78E1307E-31BC-4815-AF98-4778BF224148
  10. 10.00 10.01 10.02 10.03 10.04 10.05 10.06 10.07 10.08 10.09 10.10 10.11 10.12 10.13 10.14 10.15 10.16 10.17 10.18 10.19 10.20 10.21 10.22 "Sanofi Pasteur US Products". Retrieved 2007-12-04.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  11. Staff Writer (25 April 2011). "FDA Grants Licensure To Expand Indication For Sanofi Pasteur's Menactra". RTTNews. Retrieved 26 April 2011.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>